GoodRx Holdings Inc. (GDRX) PT Lowered to $44 at Cowen

Cowen analyst Charles Rhyee lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $44.00 (from $58.00) while maintaining an Outperform rating.

The analyst commented, "We believe shares could be weak following 2Q guide that suggests at first glance weaker than expected MAC growth and 2Q prescription transaction (RxTx) revs. What wasn't conveyed as clearly is that as GDRX converts its MACs into subscribers, more growth is captured in Other revs, rather than RxTx rev. L-T this leads to higher LTV, but we expect mgmt to balance this dynamic more going forward."

You May Also Be Interested In

• Resideo Technologies (REZI) PT Lowered to $27 at Oppenheimer
• Birkenstock Holding plc (BIRK) PT Raised to $44 at Morgan Stanley
• JPMorgan Downgrades Computershare Limited (CPU:AU) (CMSQY) to Neutral